A Sneak Peek At Electromed, Inc. ($ELMD) 1Q21 Earnings

96

Electromed, Inc. (AMEX:ELMD) is reporting first quarter earnings results on Tuesday 10th November 2020, after market close.

The consensus estimates from Thomson Reuters are loss of $ 0.05 per share.

For the full year, analysts predict revenues of $ 32.92 million, while looking forward to income of $ 0.14 per share.

Previous Quarter Performance

Electromed, Inc. outlined income for the fourth quarter of $ 0.04 per share, from the revenue of $ 6.88 million. The quarterly revenues fell 20.00 percent compared with the same quarter last year. The consensus estimates are loss of $ 0.15 per share from $ 5.68 million in revenue. The bottom line results beat street analysts by $ 0.19 or 126.67 percent, at the same time, top line results outshined analysts by $ 1.20 million or 21.13 percent.

Stock Performance

Shares of Electromed, Inc. traded up $ 0.44 or 5.23 percent on Monday, reaching $ 8.85 with volume of 137.20 thousand shares. Electromed, Inc. has traded high as $ 9.04 and has cracked $ 8.59 on the downward trend

According to the previous trading day, closing price of $ 8.85, representing a 26.85 % increase from the 52 week low of $ 6.63 and a 57.37 % decrease over the 52 week high of $ 19.73.

The company has a market capital of $ 76.12 million and is part of the Healthcare sector and Medical Devices industry.

Conference Call

Electromed, Inc. will be hosting a conference call at 5:00 PM eastern time on 10th November 2020, to discuss its 1Q21 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.smartvest.com

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products in the United States and internationally. The company offers SmartVest airway clearance system that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to patients with compromised pulmonary function; and SmartVest SQL System that provides advanced generator programmability and an enhanced pause feature with save, lock, and restore functionality.